MYGN · TickerCove

MYGNMyriad Genetics, Inc.Healthcare · Medical - Diagnostics & Researchas of 2026-09-16

Horizon

Issued 2026-09-16 at $3.86 · now $3.86 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, MYGN has typically landed between $2.88 and $4.95 — a range of −25.4% to +28.1% from the issuance price $3.86.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($3.86) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$3.86 · 19% of range

$2.86 low$8.18 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−3.3%

typical move · IQR 22.2%

−25.4%worst (p90)+28.1%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where MYGN has typically landed a month from the 2026-09-16 close of $3.86 — the range is history, not a prediction.

now $3.86 (+0.0%)
typical $3.73 (-3.3%)
middle 50% $3.3–$4.16
90% range $2.88–$4.95

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2025-04-09	−54.0%	−54.0%	+0.0%
2025-04-14	−52.5%	−52.5%	+0.0%
2026-07-01	−52.3%	−52.3%	+5.2%
3 best
2019-07-11	+80.6%	+0.0%	+87.0%
2025-08-01	+76.5%	−1.0%	+76.5%
2019-07-12	+76.0%	+0.0%	+83.0%

5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

50%

+5.5%

n=20

Feb

30%

−3.5%

n=20

Mar

55%

+1.5%

n=20

Apr

40%

−1.0%

n=20

May

45%

−2.3%

n=20

Jun

55%

+3.0%

n=20

Jul

60%

+1.6%

n=20

Aug

70%

+4.3%

n=20

Sep

45%

+1.7%

n=20

Oct

50%

+2.0%

n=20

Nov

40%

−1.5%

n=20

Dec

45%

−2.7%

n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-06-08	Kumar Rashmi	director	Sale	15,000 @ $4.46	$67K	−8.0% of holding	+37.0%	not yet — horizon still open	171,889	Form 4 · filed 1 day after the trade
2026-05-14	Bisaro Paul	director	Purchase	7,500 @ $3.69	$28K	+8.3% of holding	+18.4%	not yet — horizon still open	97,441	Form 4 · filed same day
2026-03-09	Raha Samraat S.	director	Purchase	40,000 @ $5.00	$200K	+8.8% of holding	−0.8%	−47.4%	493,104	Form 4 · filed same day
2026-02-27	Phanstiel S. Louise	director	Purchase	48,000 @ $4.66	$224K	+20.5% of holding	+2.2%	−44.2%	281,951	Form 4 · filed same day
2026-02-26	Phanstiel S. Louise	director	Purchase	50,407 @ $4.80	$242K	+27.5% of holding	−4.2%	−47.0%	233,951	Form 4 · filed 1 day after the trade
2026-02-25	Phanstiel S. Louise	director	Purchase	6,100 @ $4.74	$29K	+3.4% of holding	+3.3%	−45.8%	183,544	Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

137 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-09-03	Fox Jennifer Lynne	officer	Withheld for tax	4,398	305,964	Form 4
2026-08-16	Wheeler Benjamin Richard	officer	Withheld for tax	8,761	289,748	Form 4
2026-06-11	Donnelly Brian J	officer	Award / grant	5,000	573,363	Form 4
2026-06-11	Raha Samraat S.	director	Award / grant	3,542	1,068,083	Form 4
2026-06-04	Skovronsky Daniel	director	Award / grant	59,701	195,507	Form 4
2026-06-04	Reitan Colleen F	director	Award / grant	59,701	152,030	Form 4
2026-06-04	Newcomer Lee Nisley	director	Award / grant	59,701	191,842	Form 4
2026-06-04	Kumar Rashmi	director	Award / grant	59,701	186,889	Form 4
2026-06-04	Davis Mark Steven	director	Award / grant	59,701	106,665	Form 4
2026-06-04	Bisaro Paul	director	Award / grant	59,701	157,142	Form 4
2026-06-04	Dreismann Heinrich	director	Award / grant	59,701	231,145	Form 4
2026-06-04	Phanstiel S. Louise	director	Award / grant	59,701	341,652	Form 4
2026-06-01	Jampa Raj	officer	Award / grant	251,889	251,889	Form 4
2026-05-01	Donnelly Brian J	officer	Withheld for tax	55,975	568,363	Form 4
2026-04-14	Verratti Mark	officer	Withheld for tax	1,069	629,646	Form 4
2026-04-14	Muzzey Dale	officer	Withheld for tax	946	326,310	Form 4
2026-03-22	Verratti Mark	officer	Withheld for tax	2,055	630,715	Form 4
2026-03-22	Muzzey Dale	officer	Withheld for tax	2,019	327,256	Form 4
2026-03-22	Wheeler Benjamin Richard	officer	Withheld for tax	549	298,509	Form 4
2026-03-15	Muzzey Dale	officer	Withheld for tax	11,949	329,275	Form 4
2026-03-15	Verratti Mark	officer	Withheld for tax	9,096	632,770	Form 4
2026-03-15	Haas Kevin Richard	officer	Withheld for tax	8,382	180,022	Form 4
2026-03-15	Verratti Mark	officer	Withheld for tax	5,611	641,866	Form 4
2026-03-15	Muzzey Dale	officer	Withheld for tax	4,783	341,224	Form 4
2026-03-15	Haas Kevin Richard	officer	Withheld for tax	3,355	188,404	Form 4
2026-03-15	Wheeler Benjamin Richard	officer	Withheld for tax	2,192	299,058	Form 4
2026-03-15	Wheeler Benjamin Richard	officer	Withheld for tax	877	301,250	Form 4
2026-03-14	Raha Samraat S.	director	Withheld for tax	10,816	1,064,541	Form 4
2026-03-14	Muzzey Dale	officer	Withheld for tax	8,288	346,007	Form 4
2026-03-14	Solaiman Shereen	officer	Withheld for tax	5,784	267,801	Form 4
2026-03-14	Verratti Mark	officer	Withheld for tax	5,418	647,477	Form 4
2026-03-14	Haas Kevin Richard	officer	Withheld for tax	4,161	191,759	Form 4
2026-03-14	Wheeler Benjamin Richard	officer	Withheld for tax	1,097	302,127	Form 4
2026-03-13	Raha Samraat S.	director	Withheld for tax	36,304	1,075,357	Form 4
2026-03-13	Muzzey Dale	officer	Withheld for tax	12,779	354,295	Form 4
2026-03-13	Verratti Mark	officer	Withheld for tax	9,164	652,895	Form 4
2026-03-13	Solaiman Shereen	officer	Withheld for tax	8,899	273,585	Form 4
2026-03-13	Haas Kevin Richard	officer	Withheld for tax	6,412	195,920	Form 4
2026-03-13	Fox Jennifer Lynne	officer	Withheld for tax	5,995	310,362	Form 4
2026-03-13	Wheeler Benjamin Richard	officer	Withheld for tax	586	303,224	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i